Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Research Report

Free Access

Non-Injection Drug Use Patterns and History of Injection among Street Youth

Hadland S.E.a · Kerr T.b, c · Marshall B.D.L.b, d · Small W.b · Lai C.b · Montaner J.S.b, c · Wood E.b, c

Author affiliations

aWashington University School of Medicine, Saint Louis, Mo., USA; bBritish Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, cFaculty of Medicine and dSchool of Population and Public Health, University of British Columbia, Mather Building, Vancouver, B.C., Canada

Corresponding Author

Evan Wood, MD, PhD

BC Centre for Excellence in HIV/AIDS, St. Paul’s Hospital

608–1081 Burrard Street

Vancouver, BC V6Z 1Y6 (Canada)

Tel. +1 604 806 9116, Fax +1 604 806 9044, E-Mail uhri-ew@cfenet.ubc.ca

Related Articles for ""

Eur Addict Res 2010;16:91–98

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Aims: Efforts to prevent youth from initiating injection drug use require an understanding of the drug use patterns that predispose to injecting. Here we identify such patterns and describe the circumstances of first injection among street youth. Methods: From October 2005 to November 2007, data were collected for the At Risk Youth Study, a prospective cohort of 560 street-recruited youth aged 14–26 in Vancouver, Canada. Non-injection drug use behaviors were compared between those with and without a history of injection through multiple logistic regression. The circumstances of first injection were also examined in gender-stratified analyses. Results: Youth who had previously injected were more likely to have engaged in non-injection use of heroin or of crystal methamphetamine. Daily users of marijuana were less likely to have injected. Among prior injectors, the median age of first injection was lower among females. Females were also more likely to have had a sexual partner present at first injection and to have become a regular injector within one week of initiation. Conclusion: Preventing transition to injection among street youth may require special attention to predisposing drug use patterns and should acknowledge gender differences in the circumstances of first injection.

© 2010 S. Karger AG, Basel


  1. HIV Prevention Bulletin: Medical advice for persons who inject illicit drugs. Washington DC, Public Health Service, US Department of Health and Human Services, 1997. http://www.cdcnpin.org/reports/medadv.pdf (accessed Oct. 23, 2008).
  2. Des Jarlais DC, Friedman SR: HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS 1987;1:67–76.
  3. Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC: Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health 2004;81:14–19.
  4. Fuller CM, Borrell LN, Latkin CA, Galea S, Ompad DC, Strathdee SA, Vlahov D: Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health 2005;95:689–695.
  5. Miller CL, Strathdee SA, Kerr T, Li K, Wood E: Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health 2006;38:462–464.
  6. Farrow JA, Deisher RW, Brown R, Kulig JW, Kipke MD: Health and health needs of homeless and runaway youth. A position paper of the Society for Adolescent Medicine. J Adolesc Health 1992;13:717–726.
  7. The State of the World’s Children 1997. Oxford and New York,: UNICEF, 1997. http://www.unicef.org/sowc97/download.htm (accessed July 10, 2009).
  8. Brannigan A, Caputo T: Studying Runaways and Street Youth in Canada: Conceptual and Research Design Issues. Ottawa, Canada Ministry of Supply and Services, 1993.
  9. Kissin DM, Zapata L, Yorick R, Vinogradova EN, Volkova GV, Cherkassova E, Lynch A, Leigh J, Jamieson DJ, Marchbanks PA, Hillis S: HIV seroprevalence in street youth, St. Petersburg, Russia. AIDS 2007;21:2333–2340.
  10. Pfeifer RW, Oliver J: A study of HIV seroprevalence in a group of homeless youth in Hollywood, California. J Adolesc Health 1997;20:339–342.
  11. Roy E, Haley N, Leclerc P, Sochanski B, Boudreau JF, Boivin JF: Mortality in a cohort of street youth in Montreal. JAMA 2004;292:569–574.
  12. Street youth in Canada: findings from the enhanced surveillance of Canadian street youth, 1999–2003. Ottawa, Public Health Agency of Canada, 2006. http://www.phac-aspc.gc.ca/std-mts/reports_06/pdf/street_youth_e.pdf (accessed 16 Jun 2009).
  13. Greene JM, Ennett ST, Ringwalt CL: Substance use among runaway and homeless youth in three national samples. Am J Public Health 1997;87:229–235.
  14. Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF: Drug injection among street youths in Montreal: predictors of initiation. J Urban Health 2003;80:92–105.
  15. Kerr T, Tyndall MW, Zhang R, Lai C, Montaner JS, Wood E: Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Am J Public Health 2007;97:1228–1230.
  16. Battjes RJ, Leukefeld CG, Pickens RW: Age at first injection and HIV risk among intravenous drug users. Am J Drug Alcohol Abuse 1992;18:263–273.
  17. Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Ildefonso G, des Jarlais DC: Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001;96:847–860.
  18. Novelli LA, Sherman SG, Havens JR, Strathdee SA, Sapun M: Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend 2005;77:303–309.
  19. Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA: Factors associated with adolescent initiation of injection drug use. Public Health Rep 2001;116(suppl 1):136–145.
  20. Griffiths P, Gossop M, Powis B, Strang J: Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction 1994;89:301–309.
  21. Irwin KL, Edlin BR, Faruque S, McCoy HV, Word C, Serrano Y, Inciardi J, Bowser B, Holmberg SD: Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend 1996;42:85–92.
  22. Roy E, Haley N, Leclerc P, Cedras L, Boivin JF: Drug injection among street youth: the first time. Addiction 2002;97:1003–1009.
  23. Roy E, Nonn E, Haley N: Transition to injection drug use among street youth – a qualitative analysis. Drug Alcohol Depend 2008;94:19–29.
  24. Wood E, Stoltz JA, Zhang R, Strathdee SA, Montaner JS, Kerr T: Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev 2008;27:270–276.
  25. Clatts MC, Goldsamt L, Neaigus A, Welle DL: The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health 2003;80(4 suppl 3):iii26–iii39.
  26. Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR: Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend 2007;89:145–152.
  27. Lloyd-Smith E, Kerr T, Zhang R, Montaner JSG, Wood E: High prevalence of syringe sharing among street involved youth. Addict Res Theory 2008;16:353–358.
    External Resources
  28. Wood E, Stoltz JA, Montaner JSG, Kerr T: Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J 2006;3:18.
  29. Petchers MK, Singer MI: Perceived-Benefit-of-Drinking Scale: approach to screening for adolescent alcohol abuse. J Pediatr 1987;110:977–981.
  30. Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC: New injectors and the social context of injection initiation. Int J Drug Policy 2009;20:317–323.
  31. Reuter P, Caulkins JP: Does precursor regulation make a difference? Addiction 2003; 98:1177–1179.
  32. Wood E, Tyndall MW, Spittal PM, Li K, Anis AH, Hogg RS, Montaner JS, O’Shaughnessy MV, Schechter MT: Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ 2003;168:165–169.
  33. Lorvick J, Martinez A, Gee L, Kral AH: Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health 2006;83:497–505.
  34. Nordt C, Stohler R: Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 2006;367:1830–1834.
  35. Hadland SE, Kerr T, Li K, Montaner JS, Wood E: Access to drug and alcohol treatment among a cohort of street-involved youth. Drug Alcohol Depend 2009;101:1–7.
  36. Wood E, Kerr T, Spittal PM, Tyndall MW, O’Shaughnessy MV, Schechter MT: The healthcare and fiscal costs of the illicit drug use epidemic: the impact of conventional drug control strategies and the impact of a comprehensive approach. BCMJ 2003;45:130–136.
  37. Draus PJ, Carlson RG: Needles in the haystacks: the social context of initiation to heroin injection in rural Ohio. Subst Use Misuse 2006;41:1111–1124.
  38. Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, Morse E, Kerndt P, Maslow C, Wu Y, Vlahov D, Garfein R, Strathdee SA: Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health 2005;95:703–709.
  39. Sherman SG, Fuller CM, Shah N, Ompad DV, Vlahov D, Strathdee SA: Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J Psychoactive Drugs 2005;37:437–443.
  40. Crofts N, Louie R, Rosenthal D, Jolley D: The first hit: circumstances surrounding initiation into injecting. Addiction 1996;91:1187–1196.
  41. Diaz T, Vlahov D, Edwards V, Conover S, Monterroso E: Sex-Specific Differences in Circumstances of Initiation into Injecting-Drug Use Among Young Adult Latinos in Harlem, New York City. AIDS Behav 2002;6:117–122.
  42. Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D: Gender differences in the initiation of injection drug use among young adults. J Urban Health 2000;77:396–414.
  43. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR: Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health 2003;80:137–146.
  44. Bourgois P, Prince B, Moss A: The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum Organ 2004;63:253–264.
  45. Kane S: HIV, heroin and heterosexual relations. Soc Sci Med 1991;32:1037–1050.
  46. Latkin CA, Mandell W, Knowlton AR, Doherty MC, Vlahov D, Suh T, Celentano DD: Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev 1998;10:257–263.
  47. Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR: Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ 2001;165:293–297.
  48. Des Jarlais DC, Sloboda Z, Friedman SR, Tempalski B, McKnight C, Braine N: Diffusion of the D.A.R.E and syringe exchange programs. Am J Public Health 2006;96:1354–1358.

Article / Publication Details

First-Page Preview
Abstract of Research Report

Published online: February 03, 2010
Issue release date: March 2010

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 3

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: https://www.karger.com/EAR

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.